Shares of NLS Pharmaceutics AG (NASDAQ: NLSP) skyrocketed 124.89% at the time of writing on Friday. The strong performance of the firm has demonstrated the positive sentiments of the firm after it has signed a License Agreement with Novartis Pharma AG.
